Salix Pharmaceuticals (SLXP)

Add to Watchlists Create an Alert
60.39 +0.70  +1.17%   NASDAQ May 24, 8:00PM BATS Real time Currency in USD

Salix Pharmaceuticals Cash from Financing Quarterly:

-0.36M for March 31, 2013
View Full Chart

Salix Pharmaceuticals Cash from Financing Quarterly Chart

    Salix Pharmaceuticals Historical Cash from Financing Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 -0.36M
    Dec. 31, 2012 -16.06M
    Sept. 30, 2012 5.873M
    June 30, 2012 3.865M
    March 31, 2012 391.95M
    Dec. 31, 2011 31.84M
    Sept. 30, 2011 2.676M
    June 30, 2011 7.113M
    March 31, 2011 2.742M
    Dec. 31, 2010 4.355M
    Sept. 30, 2010 0.356M
    June 30, 2010 279.54M
    March 31, 2010 6.321M
    Dec. 31, 2009 137.88M
    Sept. 30, 2009 2.631M
    June 30, 2009 0.233M
    March 31, 2009 0.08M
    Dec. 31, 2008 0.08M
    Sept. 30, 2008 57.01M
    June 30, 2008 -0.164M
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
       
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro

    About Cash From Financing

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from financing activities. Includes the company's cash inflows and outflows from issuing cash dividends, issuing and selling stock, and adding or changing loans.
    Learn More

    Get data for

    SLXP Cash from Financing Quarterly Benchmarks

    Companies
    Valeant Pharmaceuticals International -515.92M
    Progenics Pharmaceuticals 23.46M
    Santarus 3.204M

    SLXP Cash from Financing Quarterly Rankings

    Overall 65th percentile
    2617 of 7600
    Sector 35th percentile
    418 of 653 in Healthcare
    Industry 34th percentile
    43 of 66 in Drug Manufacturers - Specialty & Generic

    SLXP Cash from Financing Quarterly Range, Past 5 Years

    Minimum -16.06M Dec 2012
    Maximum 391.95M Mar 2012
    Average 45.90M